IDH1 and neoplasm: These structural and dynamic discoveries not only highlight mechanistic properties of important tumor drivers, but also identify regions that may serve as selectivity handles when designing mutant IDH1 inhibitors requiring increasing selectivity or optimization against resistance mutants.